Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

30.98
Delayed Data
As of Jul 29
 -1.09 / -3.40%
Today’s Change
28.82
Today|||52-Week Range
46.24
-28.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues189.9M183.5M193.3M190.5M
 
 
 
 
 
Cost of Goods Sold30.9M29.7M33.8M33.6M
 
 
 
 
 
Depreciation And Amortization6.6M6.8M6.8M6.6M
 
 
 
 
 
 
Operating ExpensesGross Income152.4M147.0M152.7M150.3M
 
 
 
 
 
General Expenses116.2M103.7M107.5M107.7M
 
 
 
 
 
Research And Development18.7M17.2M16.7M17.2M
 
 
 
 
 
Total Operating Expenses153.7M140.2M148.1M147.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income36.2M43.3M45.2M42.6M
 
 
 
 
 
Other Expenses-800.0K100.0K-300.0K200.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income35.5M43.5M45.0M43.1M
 
 
 
 
 
Income Taxes-16.8M-16.9M-14.7M-10.5M
 
 
 
 
 
Net Income18.7M26.6M30.3M32.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS69.4M68.7M70.5M70.9M
 
 
 
 
 
Shares To Calculate EPS Diluted72.4M72.1M73.8M73.5M
 
 
 
 
 
 
Earnings Per ShareEPS$0.26$0.37$0.41$0.44
 
 
 
 
 
EPS Diluted$0.26$0.37$0.41$0.44